23 January 2025
THG PLC
Fourth quarter trading
statement for the period ended 31 December 2024
Successful completion of the Demerger of THG Ingenuity,
leaving THG PLC as a global, cash generative, health & wellness
consumer brands group
FY
2024 performance in-line with expectations
Gross
leverage materially reduced, c. £550m[1] year-end cash and available facilities
Continued
confidence in THG Beauty and an
improved start to the year in THG Nutrition online
and offline channels
Strategic update
· THG Ingenuity Demerger successfully completed, leaving THG PLC
as a global, cash generative, health &
wellness consumer brands group comprising THG Beauty and THG
Nutrition ("RemainCo").
· Transfer to the equity shares (commercial companies) ("ESCC")
category of the Official List now concluded (6 January 2025),
making the company eligible for index inclusion.
Outlook and guidance
· During the second half we continued to see improving
underlying trends within Nutrition particularly in the UK,
alongside promotional discipline supporting increased order
profitability and margin expansion in Beauty. Coupled with a strong
Q4 for Ingenuity, FY 2024 adjusted EBITDA is expected to be in-line
with the consensus range excluding discontinued
categories.
· RemainCo is expected to deliver mid-single digit revenue
growth in FY 2025, given continued confidence in prestige beauty
demand across our key markets, and a return to growth in Nutrition,
evidenced by a much-improved start to the year across online and
offline channels.
·
Ahead of the Demerger, FY 2025 adjusted EBITDA
assumptions were based upon:
o a
leaner, more efficient cost base and improved inventory
profile;
o continued execution of the Beauty strategy;
o a gradual reduction from the current
historic whey price highs; and
o another strong year for THG Ingenuity, supported by a pipeline
underpinning adjusted EBITDA of £40m to
£45m.
·
Whilst whey price reductions
are anticipated to be second half weighted, new global
manufacturing volumes of high concentrate whey protein will enter
the market through Q1 2025, providing optimism of a more normalised
commodity market ahead.
· Depending on the outcome of the recent UK VAT ruling for
protein powders, annual adjusted EBITDA upside could be in the
region of c. £10m.
· Over the medium term, revenue growth of mid to high-single
digit is anticipated, with adjusted EBITDA margins consistent with
historical levels (for Beauty and Nutrition), and significantly
improved free cash flow.
·
Specifically, capital
expenditure will reduce to c. £20m pa (FY 2024 pre Demerger
guidance: £100m to £110m) and cash lease costs will reduce to c.
£22m pa.
· Future cash generation will facilitate
a measured reduction in gross and net leverage, with RemainCo
targeting continued progression to a neutral net cash / net debt
position.
Q4
and FY 2024 Group Trading Performance[2]
|
Q4 2024
|
FY 2024
|
£m
|
Q4
2024
|
CCY[3]
change
|
YoY[4]
change
|
FY
2024
|
CCY
Change
|
YoY
Change
|
THG Beauty[5]
|
348.4
|
+0.8%
|
-1.3%
|
1,108.3
|
+4.6%
|
+3.3%
|
THG Nutrition
|
145.2
|
-9.5%
|
-12.7%
|
579.6
|
-8.7%
|
-11.9%
|
RemainCo (continuing) revenue
|
493.7
|
-2.5%
|
-5.0%
|
1,687.9
|
-0.4%
|
-2.5%
|
THG Ingenuity (external)
[6]
|
58.8
|
+22.0%
|
+22.9%
|
191.8
|
+16.4%
|
+15.9%
|
Group (continuing) revenue[7]
|
552.4
|
-0.4%
|
-2.6%
|
1,879.6
|
+1.1%
|
-0.9%
|
Discontinued revenue
|
13.4
|
-67.1%
|
-67.7%
|
63.0
|
-56.9%
|
-57.6%
|
Total revenue
|
565.9
|
-5.0%
|
-7.1%
|
1,942.7
|
-3.1%
|
-5.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
· Continuing revenue (including Ingenuity) of £1,879.6m (+1.1%),
with ongoing portfolio management to successfully exit loss-making
discontinued categories. Within own brand beauty, we took the
decision to withdraw from cosmetics and masstige products to focus
on the more prominent growth opportunities in prestige skincare,
spa and specialist products. This strategy is delivering margin
enhancements from a more focused, relevant consumer
offering.
·
A standout performance from THG
Beauty (+4.6%), with broad and consistent
gains across skin, cosmetics and fragrance categories in the UK,
offsetting a transitional year for THG Nutrition where promotional
activity in support of the rebrand was elevated to clear old brand
stock. The strength of the Myprotein brand is reflected in the
successful launch of multiple major brand licensing agreements, as
well as strong offline sales growth (c.+29%).[8]
· Average order values (+10% Myprotein UK and +8% on
Lookfantastic UK) and conversion rates via Apps continue to
increase (vs other channels), with 1.6m new app users in Q4 2024.
There remains significant opportunities to enhance spend and
acquire new customers to apps as we continue to improve
functionality to deliver a highly personalised
experience.
· Following the business model transformation, focusing on
larger, more profitable Enterprise clients, outturn expectations
for THG Ingenuity were upgraded in September. This positive
momentum accelerated further through Q4, delivering external
revenue growth of +23%.
· The Group has strong liquidity with c. £400m of cash and £150m
undrawn Revolving Credit Facility at the period end, ahead of the
Demerger which completed on 2 January 2025.
THG
Beauty Q4 2024 highlights
· A strong retail and own brand
performance with growth in every quarter (excl. manufacturing).
Beauty continues its strategy to deliver a leading digital customer
experience, product assortment and elevated brand positioning,
whilst generating sustainable, profitable growth with a focus on
key UK and US markets.
· During the last 18 months, refinements to the operating model,
marketing strategy and ongoing portfolio management has driven
beneficial movements in retention, order frequency and customer
lifetime value (+8% YoY). This is demonstrated by a growing
Lookfantastic loyalty scheme with 2.8m members.
· Across the UK online beauty market, Cult Beauty and
Lookfantastic were the only two participants to grow their brand
share of search[9],
strategically important as we consciously shift our marketing
efforts to a brand centric approach with customers meeting our
ideal beauty profile, less reliant on price in the long
term.
· In the UK, all categories saw YoY growth over the peak trading
period with fragrance being the standout performer (order value
+32%). Lookfantastic also recorded twice as many visits over the
cyber period than the nearest beauty peer.[10]
·
In Q4, Lookfantastic became the first specialist
beauty retailer to partner with established British brand, The
White Company, in addition to other new listings across categories
including cosmetics, fragrance and fast-growing dermatological
skincare.
THG
Nutrition Q4 2024 highlights
· The
UK had a stronger performance during Q4 (vs Q3), although well
documented challenges in the Asia market relating to FX movements
continued to weigh on trading performance in the region. To defend
margins, promotional activity was reduced whilst currency movements
and high commodity prices stabilise.
· Following the major global rebrand, decisive actions were
taken to position the business for a return to sustainable revenue
growth and margin accretion. Initiatives supporting new customer
acquisition and brand awareness through everyday great value have
been implemented, leading to growing consumer engagement and
advocacy.
· Myprotein is the most 'top-of-mind' sports nutrition brand in
the UK[11], and the category
leader in driving consumers through the purchase funnel - ranked #1
in turning brand awareness into consideration and #1 in converting
buyers into brand loyalists.[12]
· Alongside marketing strategy refinements, we have improved the
user experience through SKU rationalisation, site speed and
functionality enhancements. As a result brand recommendation is up +16% YoY, with Myprotein the UK's
most preferred sports nutrition brand.[13]
· Evolving to an on-site D2C operating model in India has
accelerated growth and new customer acquisition, as we continue to
selectively invest in developing markets where Myprotein has a
clear advantage, with a competitive quality and value
proposition.
· Licensing and retail partnerships continue to drive offline
revenue growth in the UK with 14 new licensed products launched in
H2 2024, alongside core Myprotein range extension in UK convenience
and US grocers.
0%
UK VAT protein powders Tribunal judgement, 9 January
2025
· The
Group notes the First Tier Tribunal decision in Global By Nature
Limited, selling protein products under the 'Sunwarrior' brand. The
Tribunal ruled that protein powder products sold by Sunwarrior
should be subject to 0% UK VAT, and accordingly, Sunwarrior was
eligible for a retrospective VAT repayment.
· Since the VAT rules in relation to Sports Drinks were
implemented in 2012, THG has paid UK VAT against its powdered
products in line with market practice and HMRC guidance relating to
the VAT treatment of protein powders. In the event that THG can
make a successful claim by leveraging the arguments in the recent
case, a 4-year retrospective repayment claim for two key Myprotein
powdered products - Impact Whey Protein and Impact Whey Isolate -
is estimated to be worth c. £30m.
· The
decision in its current form does not automatically entitle THG to
a VAT repayment. An update will be communicated as and when
relevant.
Matthew Moulding, CEO of THG commented
"I'm impressed by the Group's agility and resilience during a
year of significant change for THG, ranging from the
Demerger of our Ingenuity business, to the sale or discontinuation
of some non-core business units, and a major global rebrand of
Myprotein in Nutrition.
"Our Beauty business had a standout year, underpinned by
strong performances in the UK and US. The continued success of our
customer loyalty and reward program, and the opening of our
first-ever Lookfantastic physical store, further cement our
leadership position in the global Beauty market. These achievements
demonstrated significant progress against our strategic priorities
and set the stage for an even more remarkable
2025.
"Despite the transitory headwinds, Myprotein achieved several
notable successes: entry into the dairy market through the launch
of a long-term partnership with Müller; the commencement of a
co-manufacturing relationship in Japan, the expansion of our
Iceland partnership, and many other licensing and retail listing
agreements. We are excited to further deepen our retail expansion
strategy internationally in the forthcoming year.
"I
would like to thank everyone involved at THG for their immense
efforts during a transformative year for the business. I'm looking
forward to further strong progress in 2025."
Analyst and Institutional
investor conference call
THG will today host a conference
call for analysts and institutional investors at 9am (UK time)
via the following link:
https://stream.brrmedia.co.uk/broadcast/678a87af5945eb4301335497
To ask questions, you must
dial in via conference line using the below details:
·
Confirmation password: THG Q4
·
UK-Wide: +44 (0) 33 0551 0200
·
UK Toll Free: 0808 109 0700
Enquiries to:
Investor enquiries - THG PLC
|
|
Kate Grimoldby, Director of Investor
Relations and Strategic Projects
|
Investor.Relations@thg.com
|
Media enquiries:
|
|
Sodali & Co - Financial PR adviser
|
Tel: +44 (0) 20 7250 1446
|
Victoria Palmer-Moore / Russ
Lynch
|
thg@sodali.com
|
THG
PLC
|
media-enquiries@thg.com
|
Notes to editors
THG PLC is a global e-commerce group
headquartered in Manchester, UK, operating through two leading
consumer businesses: THG Beauty and THG Nutrition.
THG Beauty operates prominent online
platforms including Lookfantastic, Dermstore and Cult Beauty,
offering a valued route to market for over 1,300 third-party
brands, alongside a specialist portfolio of owned
brands.
THG Nutrition, led by Myprotein, the
world's largest online sports nutrition brand, spans multiple
health and wellness categories, delivering its products both
directly to consumers and through strategic offline partnerships
worldwide.
Cautionary Statement
Certain statements included within this announcement may
constitute "forward-looking statements" in respect of the group's
operations, performance, prospects and/or financial condition.
Forward-looking statements are sometimes, but not always,
identified by their use of a date in the future or such words and
words of similar meaning as "anticipates", "aims", "due", "could",
"may", "will", "should", "expects", "believes", "intends", "plans",
"potential", "targets", "goal" or "estimates". By their nature,
forward-looking statements involve a number of risks, uncertainties
and assumptions and actual results or events may differ materially
from those expressed or implied by those statements. Accordingly,
no assurance can be given that any particular expectation will be
met and reliance should not be placed on any forward-looking
statement. Additionally, forward-looking statements regarding past
trends or activities should not be taken as a representation that
such trends or activities will continue in the future. No
responsibility or obligation is accepted to update or revise any
forward-looking statement resulting from new information, future
events or otherwise. Nothing in this announcement should be
construed as a profit forecast. This announcement does not
constitute or form part of any offer or invitation to sell, or any
solicitation of any offer to purchase any shares or other
securities in the Company, nor shall it or any part of it or the
fact of its distribution form the basis of, or be relied on in
connection with, any contract or commitment or investment decisions
relating thereto, nor does it constitute a recommendation regarding
the shares or other securities of the Company. Past performance
cannot be relied upon as a guide to future performance and persons
needing advice should consult an independent financial adviser.
Statements in this announcement reflect the knowledge and
information available at the time of its
preparation.
Appendix
Quarterly Reported Growth Rate
|
Q1 2023
|
Q2 2023
|
Q3 2023
|
Q4 2023
|
FY
2023
|
Q1 2024
|
Q2 2024
|
Q3 2024
|
Q4 2024
|
FY
2024
|
THG
Beauty
|
222.1
|
254.0
|
244.1
|
353.1
|
1,073.3
|
248.4
|
261.3
|
250.1
|
348.4
|
1,108.3
|
THG
Nutrition
|
165.7
|
171.0
|
154.8
|
166.4
|
657.9
|
150.8
|
149.0
|
134.5
|
145.2
|
579.6
|
RemainCo (continuing)
revenue
|
387.8
|
425.0
|
398.9
|
519.5
|
1,731.2
|
399.2
|
410.4
|
384.6
|
493.7
|
1,687.9
|
THG
Ingenuity (external)
|
38.2
|
38.5
|
41.0
|
47.8
|
165.5
|
39.7
|
46.2
|
47.1
|
58.8
|
191.8
|
Group Continuing
revenue
|
426.0
|
463.5
|
440.0
|
567.3
|
1,896.7
|
438.9
|
456.6
|
431.7
|
552.4
|
1,879.6
|
Discontinued revenue
|
43.4
|
36.4
|
27.2
|
41.7
|
148.6
|
21.0
|
17.5
|
11.1
|
13.4
|
63.0
|
Total
revenue
|
469.4
|
499.9
|
467.2
|
609.0
|
2,045.4
|
459.9
|
474.0
|
442.8
|
565.9
|
1,942.7
|
|
|
|
|
|
|
|
|
|
|
|
THG
Ingenuity (internal)
|
122.3
|
126.5
|
117.4
|
153.6
|
519.9
|
112.6
|
113.0
|
98.9
|
138.3
|
462.9
|
THG
Ingenuity (total)
|
160.5
|
165.0
|
158.5
|
201.4
|
685.4
|
152.3
|
159.2
|
146.0
|
197.0
|
654.6
|
Quarterly constant currency revenue growth
rate
|
Q1 2023
|
Q2 2023
|
Q3 2023
|
Q4 2023
|
FY
2023
|
Q1 2024
|
Q2 2024
|
Q3 2024
|
Q4 2024
|
FY
2024
|
THG
Beauty
|
-14.3%
|
-9.6%
|
+0.0%
|
+2.0%
|
-5.1%
|
+13.6%
|
+3.5%
|
+3.2%
|
+0.8%
|
+4.6%
|
THG
Nutrition
|
+3.8%
|
+2.0%
|
-1.4%
|
-4.0%
|
+0.0%
|
-5.8%
|
-9.2%
|
-10.5%
|
-9.5%
|
-8.7%
|
RemainCo (continuing)
revenue
|
-7.4%
|
-5.3%
|
-0.6%
|
+0.0%
|
-3.2%
|
+5.4%
|
-1.5%
|
-2.1%
|
-2.5%
|
-0.4%
|
THG
Ingenuity (external)
|
-10.9%
|
-7.8%
|
-1.0%
|
+9.3%
|
-2.5%
|
+5.8%
|
+21.0%
|
+15.2%
|
+22.0%
|
+16.4%
|
Group Continuing
revenue
|
-7.8%
|
-5.5%
|
-0.6%
|
+0.7%
|
-3.2%
|
+5.5%
|
+0.4%
|
-0.4%
|
-0.4%
|
+1.1%
|
Discontinued revenue
|
-33.1%
|
-44.4%
|
-56.7%
|
-48.0%
|
-45.6%
|
-50.5%
|
-51.5%
|
-58.6%
|
-67.1%
|
-56.9%
|
Total
revenue
|
-11.1%
|
-10.1%
|
-7.6%
|
-5.4%
|
-8.5%
|
+0.2%
|
-3.4%
|
-3.9%
|
-5.0%
|
-3.1%
|
|
|
|
|
|
|
|
|
|
|
|
THG
Ingenuity (internal)
|
-15.5%
|
-17.1%
|
-10.5%
|
-9.0%
|
-13.0%
|
-8.0%
|
-10.6%
|
-13.5%
|
-11.7%
|
-11.0%
|
THG
Ingenuity (total)
|
-14.4%
|
-15.1%
|
-8.2%
|
-5.3%
|
-10.7%
|
-4.7%
|
-3.3%
|
-6.1%
|
-3.8%
|
-4.4%
|
Quarterly reported revenue
|
Q1 2023
|
Q2 2023
|
Q3 2023
|
Q4 2023
|
FY
2023
|
Q1 2024
|
Q2 2024
|
Q3 2024
|
Q4 2024
|
FY
2024
|
THG
Beauty
|
-10.1%
|
-8.0%
|
-1.2%
|
+1.9%
|
-3.9%
|
+11.8%
|
+2.9%
|
+2.5%
|
-1.3%
|
+3.3%
|
THG
Nutrition
|
+5.7%
|
+1.8%
|
-3.8%
|
-6.0%
|
-0.7%
|
-9.0%
|
-12.8%
|
-13.1%
|
-12.7%
|
-11.9%
|
RemainCo (continuing)
revenue
|
-3.9%
|
-4.3%
|
-2.2%
|
-0.8%
|
-2.7%
|
+2.9%
|
-3.4%
|
-3.6%
|
-5.0%
|
-2.5%
|
THG
Ingenuity (external)
|
-9.4%
|
-7.6%
|
-2.5%
|
+7.1%
|
-2.9%
|
4.1%
|
+20.0%
|
+14.7%
|
+22.9%
|
+15.9%
|
Group Continuing
revenue
|
-4.4%
|
-4.6%
|
-2.2%
|
-0.2%
|
-2.7%
|
+3.0%
|
-1.5%
|
-1.9%
|
-2.6%
|
-0.9%
|
Discontinued revenue
|
-36.1%
|
-47.7%
|
-58.8%
|
-51.4%
|
-48.6%
|
-51.6%
|
-52.0%
|
-59.0%
|
-67.7%
|
-57.6%
|
Total
revenue
|
-8.6%
|
-10.0%
|
-9.5%
|
-6.9%
|
-8.7%
|
-2.0%
|
-5.2%
|
-5.2%
|
-7.1%
|
-5.0%
|
|
|
|
|
|
|
|
|
|
|
|
THG
Ingenuity (internal)
|
-15.5%
|
-17.1%
|
-10.5%
|
-9.0%
|
-13.0%
|
-8.0%
|
-10.6%
|
-15.7%
|
-10.0%
|
-11.0%
|
THG
Ingenuity (total)
|
-14.1%
|
-15.1%
|
-8.6%
|
-5.7%
|
-10.8%
|
-5.1%
|
-3.5%
|
-7.9%
|
-2.2%
|
-4.5%
|
ENDS